Watch UEEC. Know when insiders buy.
One email the day a filing lands. Free.
UEEC
United Health Products, Inc.
0.03
−0.00 −5.71%
USD · close Oct 1
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
100
PASS · shorts 100
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $8.7MP/E —DIV YIELD —FCF YIELD —REV TTM $0NET INCOME −$1.4MNET DEBT $896K52W 0.03 – 0.10SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $0 | — | — | −$167K | −$284K | — | 0.00 | −$138K | — | — | Aug 14 |
| Q1 2026 · Mar 31 | $0 | — | — | −$266K | −$316K | — | 0.00 | −$84K | — | — | Aug 14 |
| Q4 2025 · Dec 31derived | $0 | — | — | −$265K | −$537K | — | 0.00 | −$553K | — | — | Apr 15 |
| Q3 2025 · Sep 30 | $0 | — | — | −$233K | −$286K | — | 0.00 | −$175K | — | — | Nov 14 |
| Q2 2025 · Jun 30 | $0 | — | — | −$268K | −$315K | — | 0.00 | −$185K | — | — | Aug 14 |
| Q1 2025 · Mar 31 | $0 | — | — | −$1.5M | −$1.5M | — | -0.01 | −$274K | — | — | Aug 14 |
| Q4 2024 · Dec 31derived | $0 | — | — | −$785K | −$814K | — | -0.01 | −$181K | — | — | Apr 15 |
| Q3 2024 · Sep 30 | $0 | — | — | −$392K | −$304K | — | 0.00 | −$320K | — | — | Nov 14 |
| Q2 2024 · Jun 30 | $0 | — | — | −$405K | −$432K | — | 0.00 | −$288K | — | — | Nov 14 |
| Q1 2024 · Mar 31 | $0 | — | — | −$425K | −$452K | — | 0.00 | −$406K | — | — | Nov 14 |
| Q4 2023 · Dec 31derived | $0 | — | — | −$447K | −$472K | — | 0.00 | −$577K | — | — | Mar 28 |
| Q3 2023 · Sep 30 | $0 | — | — | −$450K | −$486K | — | 0.00 | −$605K | — | — | Nov 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $0 | — | −$2.3M | −$2.7M | — | -0.01 | −$1.2M | — | — | — | — |
| FY2024 · to Dec 31 | $0 | — | −$2M | −$2M | — | -0.01 | −$1.2M | — | — | — | — |
| FY2023 · to Dec 31 | $0 | — | −$2.4M | −$2.6M | — | -0.01 | −$2.2M | — | — | $0 | — |
| FY2022 · to Dec 31 | $38K | 50.3% | −$2.8M | −$1.7M | -4500.0% | — | −$620K | — | — | $50K | — |
| FY2021 · to Dec 31 | $59 | 57.6% | −$29.8M | −$30.5M | -51778276.3% | — | −$828K | $0 | −$828K | — | — |
| FY2020 · to Dec 31 | $643 | 69.7% | −$14.8M | −$15.7M | -2443452.6% | -0.09 | −$1.3M | $101K | −$1.4M | — | — |
Every number comes from United Health Products, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.